EE171 Time to Diagnosis and Cost Effectiveness of Whole Exome Sequencing (WES) Position in the Diagnostic Pathways of Patients with Suspected Rare Genetic Disease
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.472
https://www.valueinhealthjournal.com/article/S1098-3015(23)00572-7/fulltext
Section Title :
Section Order :
11858
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00572-7&doi=10.1016/j.jval.2023.03.472